Anteris Technologies Global Corp.
NASDAQ:AVRMedical - Devices
Healthcare
$5.09 -0.16%
-$0.02 today
- Market cap
- $496.24M
- Beta
- 0.73
- P/E (TTM)
- -2.3
- EPS (TTM)
- -$4.04
52W Low $2.85High $10.14
Volume 1.26M
Average 1.18M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$77.80M
FY 2025 · Annual
Investing Cash Flow
-$596,000.00
FY 2025 · Annual
Financing Cash Flow
$20.55M
FY 2025 · Annual
-81.8% YoYCash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (17.17M) | (30.56M) | (46.76M) | (76.29M) | (94.23M) |
| Depreciation & Amortization | 640.09K | 774.08K | 1.16M | 1.51M | 1.66M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 254.85K | 2.94M | 5.76M | 0 | 7.78M |
| Change in Working Capital | 976.41K | (1.75M) | 3.99M | 6.69M | 6.26M |
| Accounts Receivables | 85.45K | (533.8K) | (345.01K) | (911K) | (515K) |
| Inventory | (15.71K) | 194.2K | (86.73K) | (71K) | 362K |
| Accounts Payables | 0 | 0 | 0 | 7.68M | 6.42M |
| Other Working Capital | 906.67K | (1.41M) | 4.42M | 0 | 0 |
| Other Non-Cash Items | 861.55K | (817.14K) | 1.23M | 6.85M | 715K |
| Operating Cash Flow | (14.44M) | (29.42M) | (34.63M) | (61.24M) | (77.8M) |
| Capital Expenditures | (582.24K) | (1.67M) | (2.39M) | (2.27M) | (1.95M) |
| Acquisitions (Net) | 0 | 0 | (213K) | 0 | 0 |
| Purchases of Investments | (311.8K) | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (1.4K) | 582.2K | 19.59K | (14K) | 1.36M |
| Investing Cash Flow | (886.07K) | (992.57K) | (2.58M) | (2.28M) | (596K) |
| Debt Repayment | 1.74M | (975.45K) | (808.05K) | (2.7M) | (1.24M) |
| Common Stock Issued | 26.91M | 25.3M | 52.82M | 115.73M | 23.02M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.23M) | (1.05M) | (2.68M) | (191K) | (1.23M) |
| Financing Cash Flow | 27.42M | 23.27M | 49.34M | 112.83M | 20.56M |
| Effect of Forex Changes | 6.88K | 1.04M | (390.9K) | 57K | (38K) |
| Net Change in Cash | 12.1M | (6.1M) | 11.74M | 49.37M | (57.88M) |
| Free Cash Flow | (15.02M) | (31.08M) | (37.03M) | (63.51M) | (79.76M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$94.2M
+ D&A$1.7M
+ Stock-Based Comp$7.8M
+ Deferred Tax$0
+ Working Capital$6.3M
+ Other Non-Cash$715.0K
= Operating Cash Flow-$77.8M
- Capex-$2.0M
= Free Cash Flow-$79.8M
Analysis
FY2025 free cash flow is -$79.8M. FCF conversion is 84.6% of net income. Operating cash flow was -$77.8M, with capex of -$2.0M. The largest bridge item is Stock-Based Comp at $7.8M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 12, 2026 | |
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 10-Q/A | 10-Q/A filing | Nov 9, 2026 | |
| 10-Q/A | 10-Q/A filing | Nov 9, 2026 | |
| ARS | ARS filing | Nov 9, 2026 |
Does AVR generate free cash flow?
Anteris Technologies Global Corp. (AVR) generated -$79.76M of free cash flow in fiscal 2025.
How much operating cash flow does AVR produce?
Operating cash flow was -$77.80M, before capital expenditures of $1.95M.
Continue the stock analysis
Jump to another research area for this company.